MB

Maina Bhaman

Partner at Sofinnova Partners

London, England

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Biotechnology
Medical Devices
Strategic Consulting
Lifesciences
Venture Capital
Entrepreneurship
Start-ups

Education

Lists including Maina

AP
AO
AS
AN

Based in UK

1884 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Investments

Myricx Bio

Seed

Total Funding: $120M

DISCO Pharmaceuticals

Seed

Total Funding: $22M

Mediar Therapeutics

Series A

Total Funding: $85M

Nuage Therapeutics

Seed

Total Funding: $13M

CinCor Pharma

Series A

Total Funding: $190M

Catamaran Bio

Series A

Total Funding: $47M

Sitryx Therapeutics

Series A

Total Funding: $30M

Autifony Therapeutics

Seed

Total Funding: $28M

Akamis Bio

Series A

Total Funding: $110M

Kuur Therapeutics

Series Unknown

Total Funding: $110M

TopiVert

Series Unknown

Total Funding: $19M

Work Experience

SP
Sofinnova Partners

2018

  • Partner

    2018

PT
PsiOxus Therapeutics

2010 - 2017

  • Investor Director

    2010 - 2017

Cellmedica

2007 - 2017

  • Non-Exec Director

    2007 - 2017

    Investor Director for Imperial Innovations

Touchstone Innovations

2006 - 2017

  • Director- Healthcare Investments

    2006 - 2017

    Investing in early stage healthcare companies

Molecular Vision

2007 - 2012

  • Non-Exec Director

    2007 - 2012

    Investor Director for Imperial Innovations

2005 - 2006

  • Independent consultant

    2005 - 2006

    Strategic Consulting, including business plan and market entry strategy for biotech start-ups

Celltech R&D

2004 - 2005

  • Scientist

    2004 - 2005

Oxford GlycoSciences

2002 - 2004

  • Scientist

    2002 - 2004

Chimeric Therapies Inc

1997 - 2002

  • Scientist

    1997 - 2002

GeneMedicine

1994 - 1997

  • Scientist

    1994 - 1997